Suppr超能文献

[足月时使用地诺前列酮阴道栓剂重复给药进行宫颈成熟]

[Cervical ripening at term with repeated administration of dinoprostone vaginal pessary].

作者信息

Petrovic Barbitch M, Gnisci A, Marcelli M, Capelle M, Guidicelli B, Cravello L, Gamerre M, Agostini A

机构信息

Service de gynécologie obstétrique, hôpital La Conception, 147 boulevard Baille, Marseille, France.

出版信息

Gynecol Obstet Fertil. 2013 Jun;41(6):346-50. doi: 10.1016/j.gyobfe.2013.02.008. Epub 2013 Apr 4.

Abstract

OBJECTIVES

To evaluate efficacy and safety of cervical ripening with repeated administration of dinoprostone slow release vaginal pessary (Propess®) in current practice.

PATIENTS AND METHODS

An observational study of 111 women who underwent cervical ripening with two Propess® during the study period from 1st July 2007 to 31st October 2011. Modes of delivery, success of cervical ripening, failure of labor induction, maternal and neonatal morbidity were reported.

RESULTS

The nulliparous rate was 75,7%. The main indications for induction of labor were post-term pregnancy in 34,3% (38/111) and premature rupture of membranes in 25,2% (28/111). The rate of vaginal delivery was 53,1% (59/111). Cesarean sections were performed for failure of labor induction in 27/52 (51,9%) and an abnormal fetal heart rate in 17/52 (32.7%). Indication for induction of labor, nulliparous patients (44 [84.6%] versus 40 [67.8%]; P=0.04), initial Bishop score (2.2±1.2 versus 2.9±1.2; P=0.04) before the cervical ripening and Bishop score before administration of second Propess® (3.3±1.4 versus 4.0±1.2; P=0.05) were significant risk factors of cesarean delivery.

DISCUSSION AND CONCLUSION

In more than half of the cases, the cervical ripening by two Propess® is efficient and allows a vaginal delivery. This practice does not appear to increase the maternal or neonatal morbidity.

摘要

目的

评估在当前临床实践中重复使用地诺前列酮缓释阴道栓剂(普贝生®)进行宫颈成熟的有效性和安全性。

患者与方法

一项观察性研究,对2007年7月1日至2011年10月31日研究期间使用两枚普贝生®进行宫颈成熟的111名女性进行研究。报告了分娩方式、宫颈成熟成功情况、引产失败情况、孕产妇和新生儿发病率。

结果

初产妇比例为75.7%。引产的主要指征为过期妊娠占34.3%(38/111),胎膜早破占25.2%(28/111)。阴道分娩率为53.1%(59/111)。因引产失败行剖宫产的有27/52(51.9%),因胎儿心率异常行剖宫产的有17/52(32.7%)。引产指征、初产妇(44 [84.6%] 对40 [67.8%];P = 0.04)、宫颈成熟前的初始 Bishop 评分(2.2±1.2 对 2.9±1.2;P = 0.04)以及第二次使用普贝生®前的 Bishop 评分(3.3±1.4 对 4.0±1.2;P = 0.05)是剖宫产的显著危险因素。

讨论与结论

在超过半数的病例中,使用两枚普贝生®进行宫颈成熟是有效的,并可实现阴道分娩。这种做法似乎不会增加孕产妇或新生儿发病率。

相似文献

1
[Cervical ripening at term with repeated administration of dinoprostone vaginal pessary].
Gynecol Obstet Fertil. 2013 Jun;41(6):346-50. doi: 10.1016/j.gyobfe.2013.02.008. Epub 2013 Apr 4.
3
Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary.
J Matern Fetal Neonatal Med. 2003 Sep;14(3):158-62. doi: 10.1080/jmf.14.3.158.162.
5
[Evaluation of controlled-release dinoprostone Propess for labor induction].
Gynecol Obstet Fertil. 2006 Jun;34(6):489-92. doi: 10.1016/j.gyobfe.2006.02.020. Epub 2006 May 19.
6
Evaluation of Propess outcomes for cervical ripening and induction of labour in full-term pregnancy.
J Obstet Gynaecol. 2014 Apr;34(3):255-8. doi: 10.3109/01443615.2013.853730. Epub 2013 Dec 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验